Corcept Therapeutics (CORT) Accounts Payables (2010 - 2026)
Corcept Therapeutics (CORT) posted Accounts Payables of $14.9 million for Q2 2026, down 55.23% sequentially from $33.3 million in Q1 2026, and down 36.62% YoY from $23.5 million in Q2 2025.
Corcept Therapeutics (CORT) Accounts Payables (2010 - 2026) Analysis & Trends
Corcept Therapeutics has reported Accounts Payables for 17 years, with the latest figure at $14.9 million in Q2 2026.
- Quarterly Accounts Payables fell 36.62% year-over-year to $14.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $14.9 million (down 36.62% YoY) and the FY2025 annual result came in at $40.4 million, up 163.03% from the prior year.
- Accounts Payables fell to $14.9 million in Q2 2026 per CORT's latest filing, from $33.3 million in the prior quarter.
- Over five years, Accounts Payables peaked at $40.4 million in Q4 2025 and troughed at $8.0 million in Q2 2023.
- A 5-year average of $18.4 million and a median of $16.0 million in 2023 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2025 and 2026: Accounts Payables surged 163.03% in 2025, then sank 36.62% in 2026.
- Over 5 years, Accounts Payables stood at $12.0 million in 2022, then jumped by 45.26% to $17.4 million in 2023, then fell by 11.61% to $15.4 million in 2024, then surged by 163.03% to $40.4 million in 2025, then tumbled by 63.13% to $14.9 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $14.9 million, $33.3 million, and $40.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 14.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.91 Mn |
| Mar 31, 2026 | 33.31 Mn |
| Dec 31, 2025 | 40.44 Mn |
| Sep 30, 2025 | 34.45 Mn |
| Jun 30, 2025 | 23.53 Mn |
| Mar 31, 2025 | 27.95 Mn |
| Dec 31, 2024 | 15.38 Mn |
| Sep 30, 2024 | 18.58 Mn |
| Jun 30, 2024 | 19.48 Mn |
| Mar 31, 2024 | 12.56 Mn |
| Dec 31, 2023 | 17.40 Mn |
| Sep 30, 2023 | 16.71 Mn |
| Jun 30, 2023 | 7.98 Mn |
| Mar 31, 2023 | 11.22 Mn |
| Dec 31, 2022 | 11.98 Mn |
| Sep 30, 2022 | 8.18 Mn |
| Jun 30, 2022 | 8.25 Mn |
| Mar 31, 2022 | 9.27 Mn |
| Dec 31, 2021 | 6.91 Mn |
| Sep 30, 2021 | 6.56 Mn |